Loading…
LFCR
Lifecore Biomedical Inc de
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 514766104
$4.540.00%Price as of Aug 29, 18:36 UTC · updated once a day, after the close
Key metrics
- Market cap
- $171.85M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- —
- Payout
- —
- EPS
- -$1.27
- ROE
- —
- Profit margin
- -23.78%
- Revenue growth
- —
- Beta
- 1.09
- 52-week high
- $8.98
- 52-week low
- $3.63
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -56.8% over 5Y.
today you would have $455.53▼ -54.4%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 16 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $8.18 | $7.43 | $6.19 | $6.48 | $11.10 | $10.85 | $11.31 | $11.84 | $12.60 | $13.80 | $11.83 | $13.81 | $12.12 | $9.51 | $5.52 | $5.98 | |
| P/E | 22.5x |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MOLNMolecular Partners AG | $4.50 | — | 2.4x | — | -61.97% | $172.37M |
| OGIOrganigram Global Inc | $1.22 | 2.8x | 0.5x | — | 17.56% | $171.32M |
| QSIQuantum-Si Inc | $0.78 | — | 0.9x | — | -49.11% | $170.73M |
| ZJYLJin Medical International Ltd. | $2.34 |
About the company
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
- 382
- Chaska, United States
Company description provided by Yahoo Finance.